Partnerships
PARTNERSHIP WITH IDEOGEN
LYSIS BIOTECH is IDEOGEN’s exclusive local representative to support Patient Access to orphan medicines for the treatment of:
- Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL NOS).
- Angioimmunoblastic T-cell lymphoma (AITL).
- Anaplastic large cell lymphoma (ALCL).
- Enteropathy associated T-cell lymphoma (EATL).
- Extra nodal natural killer (NK) cell/T-cell lymphoma.
- Peripheral T cell Lymphoma (PTCL).
- Cutaneous T cell Lymphoma (CTCL).
